ProteinQure Announces a Breakthrough Therapeutic with Remarkable Efficacy in Heterogenous Patient-Derived Xenograft Models of Triple-Negative Breast Cancer to be Presented at AACR
ProteinQure, the leading startup in the computational design of peptide drugs, announces a significant breakthrough in t…